Profile for European Patent Office Patent: 0579826
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Ireland | SPC027/2002 | ⤷ Start Trial |
| Denmark | CA 2002 00025 | ⤷ Start Trial |
| Switzerland | C00579826/01 | ⤷ Start Trial |
| United Kingdom | SPC/GB02/042 | ⤷ Start Trial |
| Netherlands | C300104 | ⤷ Start Trial |
| France | 02C0041 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 0579826
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
